USE OF PREDICTORS TO CHOOSE TREATMENT POLICY FOR THYROID CANCER

USE OF PREDICTORS TO CHOOSE TREATMENT POLICY FOR THYROID CANCER

The paper analyzes the results of treatment in patients with papillary thyroid cancer, by applying a great deal of clinical material. Different prognostic factors have been studied for their influence on the survival of the patients after surgical treatment. The most optimal treatment policy is prop...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	V. Zh. Brzhezovsky, M. V. Lomaya, T. A. Aketova
Format:	Artykuł
Język:	Russian
Wydane:	ABV-press 2015-04-01
Seria:	Опухоли головы и шеи
Hasła przedmiotowe:	thyroid cancer treatment prognosis
Dostęp online:	https://ogsh.abvpress.ru/jour/article/view/100

Podobne zapisy

COMBINED SURGERY OF SPREAD THYROID CANCER
od: V. Zh. Brzhezovsky, i wsp.
Wydane: (2015-04-01)

THE DIAGNOSIS AND TREATMENT OF MEDULLARY THYROID CANCER
od: V. Zh. Brzhezovsky, i wsp.
Wydane: (2015-04-01)

A RARE CASE OF THYROID CANCER METASTASIS TO PARAPHARYNGEAL LYMPH NODES
od: V. Zh. Brzhezovsky, i wsp.
Wydane: (2015-04-01)

SURGICAL TREATMENT FOR GENERALIZED SKIN CANCER OF THE FOREHEAD (2 CLINICAL CASES)
od: V. Zh. Brzhezovsky, i wsp.
Wydane: (2015-04-01)

The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis
od: Hongen Guo, i wsp.
Wydane: (2024-03-01)

ANAPLASTIC THYROID CARCINOMA
od: Augusto eTaccaliti, i wsp.
Wydane: (2012-07-01)

FOLLICULAR THYROID CANCER: COURSE AND TREATMENT
od: M. A. Engibaryan, i wsp.
Wydane: (2015-04-01)

Thyroid Papillary Microcarcinoma: Diagnostic and Treatment Approaches
od: Evren Erkul
Wydane: (2014-12-01)

The prognostic power of gene mutations in thyroid cancer
od: Sara Ahmadi, i wsp.
Wydane: (2024-01-01)

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
od: Xiaoxin Xu, i wsp.
Wydane: (2023-11-01)

Deaths related to differentiated thyroid cancer: a rare but real event
od: Ana Kober N. Leite, i wsp.
Wydane: (2017-03-01)

Prognosis and influencing factors of follicular thyroid cancer
od: Jiafei Shen, i wsp.
Wydane: (2024-01-01)

Clinical and histopathological features of follicular thyroid cancer in Chile
od: René Díaz, i wsp.
Wydane: (2023-01-01)

Editorial: Papillary thyroid cancer: prognostic factors and risk assessment
od: Vincenzo Marotta, i wsp.
Wydane: (2025-03-01)

Unmet Clinical Needs in the Treatment of Patients with Thyroid Cancer
od: Won Bae Kim, i wsp.
Wydane: (2020-03-01)

Editorial: Targeting different programmed cell death processes as therapeutic modalities for thyroid cancer
od: Sadegh Rajabi
Wydane: (2023-07-01)

Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer
od: Mayara Peres Barbosa, i wsp.

Knowledge mapping of anaplastic thyroid cancer treatments: a bibliometric analysis (2000-2023)
od: Shiqiang Liu, i wsp.
Wydane: (2024-02-01)

Results of Surgical Treatment of Papillary Thyroid Cancer
Wydane: (2014-06-01)

Associations between Hashimoto Thyroiditis and Clinical Outcomes of Papillary Thyroid Cancer: A Meta-Analysis of Observational Studies
od: Shinje Moon, i wsp.
Wydane: (2018-11-01)

Treatment Outcome and Prognostic Factors of Anaplastic Thyroid Carcinoma: A Single Institution Experience in Egypt
od: Dina Ibrahim, i wsp.
Wydane: (2018-06-01)

Editorial: New strategies in treatment of differentiated thyroid carcinoma
od: Jose Federico Carrillo, i wsp.
Wydane: (2022-08-01)

Immunohistochemical Analysis of Cancer Stem Cell Marker Expression in Papillary Thyroid Cancer
od: Hye Min Kim, i wsp.
Wydane: (2019-08-01)

Development of a thyroid cancer prognostic model based on the mitophagy-associated differentially expressed genes
od: Wencong Sun, i wsp.
Wydane: (2023-09-01)

Treatment adherence and quality of life among thyroid cancer patients
od: Naruepai Somruedee, i wsp.
Wydane: (2010-04-01)

Diagnosis and treatment of ectopic thyroid carcinoma: A case report and literature review
od: Guiming Fu, i wsp.
Wydane: (2022-11-01)

The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis
od: Haonan Zhang, i wsp.
Wydane: (2024-02-01)

Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer
od: Sunghwan Suh, i wsp.
Wydane: (2020-06-01)

RELATIONSHIP BETWEEN THYROID STIMULATING HORMONE AND THYROID CANCER
od: Chernenko O. V.
Wydane: (2018-12-01)

The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update
od: Robert Aurelian Tiucă, i wsp.
Wydane: (2023-04-01)

Nomograms for estimating survival in patients with papillary thyroid cancer after surgery
od: Liu G, i wsp.
Wydane: (2019-04-01)

SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer
od: Meihua Jin, i wsp.
Wydane: (2021-06-01)

Multiple primary cancers of the colon, rectum, and the thyroid gland
od: Zubaidi Ahmad
Wydane: (2008-01-01)

PREDICTORS OF AGGRESSIVE DIFFERENTIATED THYROID CANCER. A REPORT OF A CASE OF PAPILLARY THYROID CANCER
od: R. A. Murashko, i wsp.
Wydane: (2017-11-01)

Current Status and Future Perspectives in Differentiated Thyroid Cancer
od: Tae Yong Kim, i wsp.
Wydane: (2014-09-01)

Lobo-isthmectomy in the management of differentiated thyroid cancer
od: Jolanta Krajewska, i wsp.
Wydane: (2023-02-01)

Peculiarities of operative treatment of goiter on background of autoimmune thyroiditis
od: O. P. Kovalov, i wsp.
Wydane: (2020-05-01)

Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?
od: Zhen Wu, i wsp.
Wydane: (2021-03-01)

The diagnostic performance of neck ultrasound in follow-up of advanced stage differentiated thyroid cancer
od: Vicki Munro, i wsp.
Wydane: (2024-10-01)

Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer
od: Laura Valerio, i wsp.
Wydane: (2025-02-01)